People / Scott Benfield

Whether in his role providing regulatory advice or as trademark counsel, Scott Benfield takes a disciplined approached to his practice providing clients with the confidence that their issues are receiving the attention they deserve.

During his career, Scott has advised a wide array of clients, including numerous Fortune 500 companies, on complex international trade and U.S. economic sanctions issues, with a specific focus on the export of defense articles regulated under the International Traffic in Arms Regulations (ITAR), as well as, hardware and software containing encryption functionality regulated under the Export Administration Regulations (EAR). Scott has assisted companies with formulating regulatory compliance programs which manage the difficult task of balancing compliance with maintaining viable business practices. When problems arise, Scott has guided clients through internal investigations and the voluntary disclosure process for matters before the U.S. Departments of State, Treasury and Commerce.

Apart from his regulatory work, Scott also provides counsel on trademark and copyright issues, providing guidance on the application process as well as the filing and responding to trademark opposition and cancelation proceedings.

Scott is very active in Washington, D.C. pro bono activities, having represented clients in Social Security disability appeals as well as landlord/tenant disputes.

Professional and Community Activities

  • Maryland State Bar Association
Show More
Qualifications

Education

B.A., University of Florida, 1994,

with honors

J.D., George Mason University School of Law, 2000

M.A., State University of New York at Buffalo, 1997

Admissions

District of Columbia

Maryland

Press Release
Haynes and Boone Secures Patent Trial Victory for Prinston Pharmaceutical
June, 14 2017

Haynes and Boone, LLP won a complete victory in New Jersey federal court for client Prinston Pharmaceutical Inc., a generic drug company. Prinston is seeking to market a generic version of Brisdelle®, a non-hormonal (i.e., non-estrogen based) treatment for hot flashes associated with menopause. Plaintiff Sebela International Limited filed a Hatch-Waxman suit against Prinston and other drug compani [...]